Repositori institucional URV
Español Català English

TÍTULO:

Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia. - imarina:9453282

Autor/es de la URV:Martorell Bonet, Lourdes
Autor según el artículo:Morén C; Olivares-Berjaga D; Martínez-Pinteño A; Bioque M; Rodríguez N; Gassó P; Martorell L; Parellada E
Direcció de correo del autor:lourdes.martorell@urv.cat
Identificador del autor:0000-0003-4999-2197
Año de publicación de la revista:2025
Tipo de publicación:Journal Publications
Referencia al articulo segun fuente origial:International Journal Of Molecular Sciences. 26 (9):
Resumen:Schizophrenia (SCZ) is a severe, chronic mental disorder of unknown etiology and limited therapeutic options. Bioenergetic deficits in the oxidative phosphorylation system (OXPHOS) during early postnatal brain development may underlie disrupted neuronal metabolism and synaptic signaling, contributing to the neurodevelopmental and behavioral disturbances observed in patients. This narrative review summarizes updated evidence linking mitochondrial-OXPHOS dysfunction to SCZ pathophysiology. The novelty lies in the focus on OXPHOS dysfunction at the enzymatic/functional level, rather than on genetic, transcriptional, or oxidative parameters. While complex I impairment has long been highlighted and proposed as a peripheral marker of the disease, recent studies also report alterations in other OXPHOS complexes and their precursors. These findings suggest that OXPHOS dysfunction is not isolated to a single enzymatic component but affects broader mitochondrial function, alongside oxidative stress, contributing to disease progression through mechanisms involving apoptosis, accelerated aging, and synaptic deterioration. OXPHOS dysfunction in both central and peripheral tissues further supports its relevance to SCZ. Overall, the literature points to mitochondrial OXPHOS abnormalities as a significant biological feature of SCZ. Whether these alterations are causal factors or consequences of disease processes remains unclear. Understanding OXPHOS dysregulation may open new avenues for targeted therapies.
DOI del artículo:10.3390/ijms26094415
Enlace a la fuente original:https://www.mdpi.com/1422-0067/26/9/4415
Versión del articulo depositado:info:eu-repo/semantics/publishedVersion
Acceso a la licencia de uso:https://creativecommons.org/licenses/by/3.0/es/
Departamento:Medicina i Cirurgia
URL Documento de licencia:https://repositori.urv.cat/ca/proteccio-de-dades/
Áreas temáticas:Zootecnia / recursos pesqueiros
Spectroscopy
Saúde coletiva
Química
Psicología
Physical and theoretical chemistry
Organic chemistry
Odontología
Nutrição
Molecular biology
Medicine (miscellaneous)
Medicina veterinaria
Medicina iii
Medicina ii
Medicina i
Materiais
Interdisciplinar
Inorganic chemistry
Geociências
Farmacia
Engenharias iv
Engenharias ii
Engenharias i
Educação física
Computer science applications
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Ciências ambientais
Ciências agrárias i
Ciência de alimentos
Ciência da computação
Chemistry, multidisciplinary
Catalysis
Biotecnología
Biodiversidade
Biochemistry & molecular biology
Astronomia / física
Palabras clave:Schizophrenia
Oxphos
Oxidative stress
Oxidative phosphorylation
Mitochondria
Metabolism
Humans
Brain
Bioenergetics
Animals
Entidad:Universitat Rovira i Virgili
Fecha de alta del registro:2025-05-17
Busca tu registro en:

Archivos desponibles
ArchivoDescripciónFormato
DocumentPrincipalDocumentPrincipalapplication/pdf


Información

© 2011 Universitat Rovira i Virgili